Anticardiolipin Antibodies in Patients with Type 2 Diabetes Mellitus
- 26 February 2009
- journal article
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 7 (3) , 93-95
Abstract
There is controversy about an increased prevalence of antiphospholipid antibodies in diabetic patients. The possible implications are little known. We prospectively studied all consecutive outpatients with type 2 diabetes mellitus (DM) attended to in an Internal Medicine office. IgM and IgG anticardiolipin antibodies (ACA) were determined by standardized enzyme-linked immunoassay. Fifty-six patients were included. Only one patient (1.8%) had a titer of IgM ACA higher than 15 MPL units and no patient had a titer of IgG ACA higher than 15 GPL units. Six patients (10.7%) had low IgM ACA titers (4-15 MPL units) and 18 patients (32.1%) had low IgG ACA titers (4-15 GPL units). There were no differences in the frequencies of a low IgM or IgG ACA titer or in the means of IgM and IgG ACA titers in patients with complicated and uncomplicated DM, with and without cardiovascular disease, with and without nephropathy, or with and without retinopathy. Moderate to high ACA titers must be exceptional in patients with type 2 DM. Low ACA titers may occur in patients with type 2 DM. These low titers do not seem to be associated with complicated DM, cardiovascular disease, nephropathy or retinopathy.Keywords
This publication has 10 references indexed in Scilit:
- Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis?2007
- Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?Rheumatic Disease Clinics of North America, 2006
- Anticardiolipin and anti-β2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2005
- Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individualsJournal of Diabetes and its Complications, 2005
- Diabetes mellitusJournal of Diabetes and its Complications, 2001
- Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitusClinical and Experimental Immunology, 1999
- Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?Lupus, 1998
- A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with InfectionLupus, 1992
- Anticardiolipin antibody levels in diabetic subjects with and without coronary artery diseasePostgraduate Medical Journal, 1989
- Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.1989